* US FDA panel says drug helped patients breathe * Panelists call for post-approval safety studies * Forest shares up 1.2 pct * FDA to make final decision by April 23 By Anna Yukhananov SILVER SPRING, Md., Feb 23 (Reuters) - An experimental inhaled lung treatment from Forest Laboratories Inc and Almirall SA won the support of a U.S.